As adoptive cell therapies become more specialized, understanding how engineered immune cells recognize diseased targets is increasingly important. Human leukocyte antigen (HLA) molecules play a central role in presenting peptide targets to engineered T cells, but their extensive variability can complicate therapeutic design and functional testing. Researchers need reliable systems that allow controlled evaluation of HLA-specific interactions, target recognition, and immune activation.
This poster examines engineered cell platforms developed to support HLA-informed therapeutic research, including tools for allele-specific screening, controlled HLA expression, and functional assessment of T cell responses in co-culture models.
Download this poster to learn:
- How engineered cell lines can support HLA-specific therapeutic screening
- Approaches for restoring defined HLA expression in knockout cell models
- Methods for evaluating T cell activation in HLA-dependent assays
